News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kastenmayer James Paul
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/24/2023 |
4
| Kastenmayer James Paul (General Counsel) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.44, valued at
$220k
|
|
| 08/25/2022 |
4
| Kastenmayer James Paul (Interim CEO & General Counsel) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $0.68, valued at
$88.4k
|
|
| 08/25/2022 |
3
| Kastenmayer James Paul (Interim CEO & General Counsel) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| Kastenmayer James Paul (General Counsel) has filed a Form 4 on Viela Bio, Inc.|
Txns:
| Granted 50,000 options to buy
@ $37.55, valued at
$1.9M
|
|
| 01/15/2020 |
3
| Kastenmayer James Paul (General Counsel) has filed a Form 3 on Viela Bio, Inc. |
|
|